Long-term survivals after allogeneic heart grafts in dogs, physiological, morphological and bio-immunological considerations.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D000906:Antibodies; D000961:Antilymphocyte Serum; D001285:Atropine / Q000494:pharmacology; D001379:Azathioprine / Q000494:pharmacology; D001835:Body Weight / Q000187:drug effects; D003402:Creatine Kinase / Q000097:blood; D004285:Dogs; D004562:Electrocardiography; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000187:drug effects; D006321:Heart / Q000033:anatomy & histology / Q000187:drug effects / Q000294:innervation / Q000502:physiology; D006327:Heart Block / Q000209:etiology; D006339:Heart Rate / Q000187:drug effects; D016027:Heart Transplantation; D007165:Immunosuppression Therapy; D007958:Leukocyte Count; D009206:Myocardium / Q000276:immunology; D011247:Pregnancy; D011379:Prognosis; D014184:Transplantation, Homologous / Q000401:mortality
D000906:Antibodies; D000961:Antilymphocyte Serum; D001285:Atropine; D003402:Creatine Kinase; D001379:Azathioprine; D000109:Acetylcholine; D004837:Epinephrine